Increased p53 activity does not accelerate telomere-driven ageing

EMBO Reports

Volumn 7, Issue 5, 2006, Pages 546-552

  García Cao, Isabel ^a   García Cao, Marta ^a   Tomás Loba, Antonia ^a   Martín Caballero, Juan ^a   Flores, Juana M ^b   Klatt, Peter ^a   Blasco, María A ^a   Serrano, Manuel ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Ageing; DNA damage; p53; Telomeres; Tumour suppression

Indexed keywords

DNA; PROTEIN P53; TELOMERASE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; GENETIC ANALYSIS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TELOMERE;

AGING; ANIMALS; GENE DOSAGE; KINETICS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TELOMERASE; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 33745223517     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400667     Document Type: Article

References (40)

1. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645
2. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106: 661-673
3. Blasco MA (2003) Telomeres in cancer and aging: Lessons from the mouse. Cancer Lett 194: 183-188
4. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34
5. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361: 393-395
6. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538
7. Cohn SM, Roth KA, Birkenmeier EH, Gordon JI (1991) Temporal and spatial patterns of transgene expression in aging adult mice provide insights about the origins, organization, and differentiation of the intestinal epithelium. Proc Natl Acad Sci USA 88: 1034-1038
8. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198
9. de Lange T (2002) Protection of mammalian telomeres. Oncogene 21: 532-540
10. Espejel S, Franco S, Rodriguez-Perales S, Bouffler SD, Cigudosa JC, Blasco MA (2002a) Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J 21: 2207-2219
11. Espejel S, Franco S, Sgura A, Gae D, Bailey SM, Taccioli GE, Blasco MA (2002b) Functional interaction between DNA-PKcs and telomerase in telomere length maintenance. EMBO J 21: 6275-6287
12. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill JC, Blasco MA, Serrano M (2002) 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 21: 6225-6235
13. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J, Varmus HE (1996) Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10: 836-850
14. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA (2000) Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26: 114-117
15. Goytisolo FA, Blasco MA (2002) Many ways to telomere dysfunction: In vivo studies using mouse models. Oncogene 21: 584-591
16. Guglielmi L, Le Bert M, Truffinet V, Cogne M, Denizot Y (2003) Insulators to improve expression of a 3(′)IgH LCR-driven reporter gene in transgenic mouse models. Biochem Biophys Res Common 307: 466-471
17. Hao LY, Strong MA, Greider CW (2004) Phosphorylation of H2AX- at short telomeres in T cells and fibroblasts. J Biol Chem 279: 45148-45154
18. Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J (2003) Aging and genome maintenance: Lessons from the mouse? Science 299: 1355-1359
19. Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA (1999) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18: 2950-2960
20. Joeng KS, Song EJ, Lee KJ, Lee J (2004) Long lifespan in worms with long telomeric DNA. Nat Genet 36: 607-611
21. Lee HW, Blasco MA, Gottlieb GJ, Horner II JW, Greider CW, DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574
22. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P, Blasco MA (2003) Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 22: 131-139
23. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
24. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, Sutherland A, Thorner M, Scrable H (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev 18: 306-319
25. Matheu A, Pantoja C, Efeyan A, Criado LM, Martin-Caballero J, Flores JM, Klatt P, Serrano M (2004) Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev 18: 2736-2746
26. Mendrysa SM, O'Leary KA, McElwee MK, Michalowski J, Eisenman RN, Powell DA, Perry ME (2006) Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev 20: 16-21
27. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP, Hall PA (1995) Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 108: 1843-1848
28. Nakamura T, Pichel JG, Williams-Simons L, Westphal H (1995) An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc Natl Acad Sci USA 92: 6142-6146
29. Palmero I, Serrano M (2001) Induction of senescence by oncogenic Ras. Methods Enzymol 333: 247-256
30. Robertson G, Garrick D, Wilson M, Martin DI, Whitelaw E (1996) Age-dependent silencing of globin transgenes in the mouse. Nucleic Acids Res 24: 1465-1471
31. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712
32. Samper E, Goytisolo FA, Slijepcevic P, van Buul PP, Blasco MA (2000) Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep 1: 244-252
33. Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 6: 168-170
34. Sharpless NE, DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113: 160-168
35. Smogorzewska A, de Lange T (2002) Different telomere damage signaling pathways in human and mouse cells. EMBO J 21: 4338-4348
36. Sutherland HG, Martin DI, Whitelaw E (1997) A globin enhancer acts by increasing the proportion of erythrocytes expressing a linked transgene. Mol Cell Biol 17: 1607-1614
37. Takai H, Smogorzewska A, de Lange T (2003) DNA damage foci at dysfunctional telomeres. Curr Biol 13: 1549-1556
38. Tyner SD et al (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53
39. Von Zglinicki T (2003) Replicative senescence and the art of counting. Exp Gerontol 38: 1259-1264
40. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413: 432-435